Full mutation phenotype |
Fragile X syndrome, fragile X–associated disorders, fragile X premutation, fragile X carrier, fragile X–associated tremor/ataxia syndrome, or fragile X–associated primary ovarian insufficiency and phenotype, clinical presentation, clinical description, neurocognitive, cognitive, behavior, social-emotional, or language, communication |
2008–2014 |
English language Human United States only |
Developmental trajectories across the life span |
Fragile X syndrome or fragile X and lifespan, developmental, longitudinal, adolescent, adult, services, or transition to adulthood |
1991–2014 |
English language Human |
Available interventions and treatments |
Fragile X syndrome or fragile X and treatment, intervention, pharmacological, educational, behavioral, medication, or clinical trial |
1991–2014 |
English language Human |
Impact on family |
Fragile X syndrome or fragile X and family adaptation, family impact, family outcomes, burden, or cost of care |
1991–2014 |
English language Human United States only |